Stock listing

ARWR Stock Price, News, Filings & Events — Arrowhead Pharmaceuticals, Inc.

Selected listing: ARWR · BOATS · USD · US

This page tracks Arrowhead Pharmaceuticals, Inc.'s ARWR:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARWR:BOATS. ARWR:BOATS is the stock-level entry point for investors researching Arrowhead Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. The company has a market capitalization of approximately $12.06 billion. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.

ARWR:BOATSUSDUSUpdated August 14, 2026
Arrowhead Pharmaceuticals, Inc. logo
Ticker
ARWR:BOATS
Asset type
Stock
Market cap
$12.24B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Arrowhead Pharmaceuticals, Inc. ARWR:BOATS stock context

This page tracks Arrowhead Pharmaceuticals, Inc.'s ARWR:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARWR:BOATS. ARWR:BOATS is the stock-level entry point for investors researching Arrowhead Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. The company has a market capitalization of approximately $12.06 billion. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.

Research Arrowhead Pharmaceuticals, Inc.

Alternate listings